Wealthfront Advisers’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $911K | Sell |
5,945
-1,307
| -18% | -$200K | ﹤0.01% | 696 |
|
|
2025
Q1 | $1.14M | Buy |
7,252
+1,455
| +25% | +$229K | ﹤0.01% | 635 |
|
|
2024
Q4 | $910K | Buy |
5,797
+1,261
| +28% | +$198K | ﹤0.01% | 681 |
|
|
2024
Q3 | $805K | Buy |
4,536
+50
| +1% | +$8.87K | ﹤0.01% | 688 |
|
|
2024
Q2 | $755K | Buy |
4,486
+1,021
| +29% | +$172K | ﹤0.01% | 674 |
|
|
2024
Q1 | $576K | Buy |
3,465
+526
| +18% | +$87.5K | ﹤0.01% | 713 |
|
|
2023
Q4 | $486K | Sell |
2,939
-2,290
| -44% | -$379K | ﹤0.01% | 726 |
|
|
2023
Q3 | $814K | Buy |
5,229
+1,292
| +33% | +$201K | ﹤0.01% | 599 |
|
|
2023
Q2 | $614K | Buy |
3,937
+1,549
| +65% | +$242K | ﹤0.01% | 646 |
|
|
2023
Q1 | $387K | Buy |
2,388
+14
| +0.6% | +$2.27K | ﹤0.01% | 712 |
|
|
2022
Q4 | $379K | Buy |
2,374
+357
| +18% | +$57K | ﹤0.01% | 680 |
|
|
2022
Q3 | $284K | Buy |
2,017
+176
| +10% | +$24.8K | ﹤0.01% | 698 |
|
|
2022
Q2 | $268K | Sell |
1,841
-59
| -3% | -$8.59K | ﹤0.01% | 706 |
|
|
2022
Q1 | $308K | Buy |
1,900
+1
| +0.1% | +$162 | ﹤0.01% | 704 |
|
|
2021
Q4 | $360K | Sell |
1,899
-340
| -15% | -$64.5K | ﹤0.01% | 647 |
|
|
2021
Q3 | $452K | Buy |
+2,239
| New | +$452K | ﹤0.01% | 574 |
|